Course Overview

People living with diabetes face many challenges, but losing their eyesight shouldn’t be one of them. Diabetic retinopathy (DR) is the leading cause of blindness in working-age adults and affects four of every ten people with diabetes. But only half of those who should be screened for diabetic retinopathy are screened, leaving the rest vulnerable to vision loss that is frequently not detected until it is too late. Part of providing better diabetes care is early detection of DR. Timely treatment of diabetic retinopathy can reduce the risk of vision loss by 95%. This free CME/CE activity provides primary care clinicians with a simple, evidence-based approach to the routine screening, diagnosis, and management of DR with patient case studies that help you get better.
David S. Friedman
David S. Friedman, MD, MPH, PhD

Albert and Diane Kaneb Chair, Massachusetts Eye and Ear Director of Glaucoma and Medical Director for Clinical Research Co-Director of the Glaucoma Center of Excellence Professor, Harvard Medical School